Peroxisomal ABC transporters and X-linked adrenoleukodystrophy

Laboratoire Bio-PeroxIL, biochimie du peroxysome, inflammation et métabolisme lipidique EA7270, université de Bourgogne, 6, boulevard Gabriel, 21000 Dijon, France.
Medecine sciences: M/S (Impact Factor: 0.67). 12/2012; 28(12):1087-94. DOI: 10.1051/medsci/20122812019
Source: PubMed


X-linked adrenoleukodystrophy (X-ALD) is a complex neurodegenerative disease associated with mutations in the ABCD1 gene, which encodes for a peroxisomal ABC transporter. Thanks to the efforts of the ELA foundation and to the recent successes of gene therapy published in Science in 2009, X-ALD is better known but still remains poorly understood. The exact role of ABCD1 and its homologs, as well as the exact link between the biochemical and metabolic peroxisomal defects and the clinical symptoms of the disease remain to be elucidated. This review summarizes the knowledge concerning the subfamily D of the ABC transporter family and concerning X-ALD, the most frequent peroxisomal disorder.

26 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Peroxisomes are essential organelles in higher eukaryotes as they play a major role in numerous metabolic pathways and redox homeostasis. Some peroxisomal abnormalities, which are often not compatible with life or normal development, were identified in severe demyelinating and neurodegenerative brain diseases. The metabolic roles of peroxisomes, especially in the brain, are described and human brain peroxisomal disorders resulting from a peroxisome biogenesis or a single peroxisomal enzyme defect are listed. The brain abnormalities encountered in these disorders (demyelination, oxidative stress, inflammation, cell death, neuronal migration, differentiation) are described and their pathogenesis are discussed. Finally, the contribution of peroxisomal dysfunctions to the alterations of brain functions during aging and to the development of Alzheimer's disease is considered.
    Biochimie 03/2014; 98:102-10. DOI:10.1016/j.biochi.2013.09.009 · 2.96 Impact Factor
  • Source